Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 4
2015 6
2016 8
2017 3
2018 6
2019 4
2020 3
2021 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma.
Tanabe Y, Suehara Y, Kohsaka S, Hayashi T, Akaike K, Mukaihara K, Kurihara T, Kim Y, Okubo T, Ishii M, Kazuno S, Kaneko K, Saito T. Tanabe Y, et al. Among authors: akaike k. Oncotarget. 2018 Feb 12;9(18):14428-14443. doi: 10.18632/oncotarget.24467. eCollection 2018 Mar 6. Oncotarget. 2018. PMID: 29581854 Free PMC article.
IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma.
Sasa K, Saito T, Kurihara T, Hasegawa N, Sano K, Kubota D, Akaike K, Okubo T, Hayashi T, Takagi T, Yao T, Ishijima M, Suehara Y. Sasa K, et al. Among authors: akaike k. Discov Oncol. 2021 Nov 30;12(1):57. doi: 10.1007/s12672-021-00453-2. Discov Oncol. 2021. PMID: 35201455 Free PMC article. Retracted.
KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors.
Suehara Y, Akaike K, Mukaihara K, Kurisaki-Arakawa A, Kubota D, Okubo T, Mitomi H, Mitani K, Takahashi M, Toda-Ishii M, Kim Y, Tanabe Y, Takagi T, Hayashi T, Mogushi K, Kaneko K, Yao T, Saito T. Suehara Y, et al. Among authors: akaike k. Oncotarget. 2018 Jun 5;9(43):27016-27026. doi: 10.18632/oncotarget.25469. eCollection 2018 Jun 5. Oncotarget. 2018. PMID: 29930747 Free PMC article.
Protein Expression Profiles Corresponding to Histological Changes with Denosumab Treatment in Giant Cell Tumors of Bone.
Suehara Y, Okubo T, Kurihara T, Hayashi T, Kohsaka S, Kazuno S, Sano K, Hasegawa N, Miura Y, Akaike K, Kim Y, Takamochi K, Takahashi F, Ueno T, Kaneko K, Saito T. Suehara Y, et al. Among authors: akaike k. Proteomics Clin Appl. 2019 Sep;13(5):e1800147. doi: 10.1002/prca.201800147. Epub 2019 Jul 22. Proteomics Clin Appl. 2019. PMID: 31287244
Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens.
Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F, Takahashi K, Takamochi K, Suzuki K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, Nagase T, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku M, Miyazono K, Miyagawa K, Aburatani H, Mano H. Kohsaka S, et al. Among authors: akaike k. Cancer Sci. 2019 Apr;110(4):1464-1479. doi: 10.1111/cas.13968. Epub 2019 Mar 5. Cancer Sci. 2019. PMID: 30737998 Free PMC article.
37 results